The Effect of Patient's Position After Intra-tympanic Injection on the Amount of Fluid in the Middle Ear
NCT04449848 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-06-29
Summary
During the regular protocol of Intra-tympanic injections of Dexamethasone to the middle ear due to Sudden Sensorineural Hearing Loss, the patients will be sitted once after the injection instead of lying down. They will be then asked to rate their taste as a reference to the amount of fluid leaking to the throat through the eustachian tube.
Conditions
- Sudden Hearing Loss
Interventions
- OTHER
-
Sitting after intra tympanic injection
Sitting after intra tympanic injection
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2021-07-31
- Completion
- 2021-07-31
More Related Trials
-
Intratympanic Steroids for Sudden Hearing Loss
NCT04129697 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of Tinnitus
NCT03265197 ·Status: COMPLETED ·Phase: PHASE1
-
Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss
NCT06878599 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
NCT06437054 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells
NCT04397354 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing Loss
NCT06968507 ·Status: RECRUITING ·Phase: PHASE4
-
High Dose Oral Steroids in Sudden Sensorineural Hearing Loss
NCT03255473 ·Status: WITHDRAWN ·Phase: PHASE2
-
Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation
NCT01588925 ·Status: COMPLETED ·Phase: PHASE2
-
Intracochlear Injection of Glucocorticoid
NCT07134075 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission
NCT00945386 ·Status: UNKNOWN
-
Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis Media
NCT05133258 ·Status: COMPLETED
-
Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection
NCT04794842 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus
NCT04798391 ·Status: UNKNOWN ·Phase: PHASE4
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3
NCT01925495 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Single-Sided Deafness and Asymmetric Hearing Loss
NCT04506853 ·Status: RECRUITING ·Phase: NA
-
Observation of Gas Exchange in the Middle Ear
NCT00794105 ·Status: UNKNOWN
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
NCT00694421 ·Status: COMPLETED
-
Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment
NCT01372904 ·Status: COMPLETED ·Phase: PHASE4
-
Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery
NCT03374514 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Simethicone on Eustachian Tube Dysfunction
NCT01312038 ·Status: COMPLETED ·Phase: PHASE2
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c
NCT00422851 ·Status: COMPLETED
-
Device Study to Evaluate the Detection and Characterization of Middle Ear Fluid in Children
NCT01421199 ·Status: UNKNOWN ·Phase: NA
-
Autologous Blood Monocyte Vesicles for the Treatment of Sudden Deafness
NCT06707389 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids
NCT03974867 ·Status: UNKNOWN ·Phase: NA
-
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508 ·Status: RECRUITING ·Phase: PHASE3